Health

Results: 469-480 of 6053

Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins

Business Wire logo

Incyte Announces Multiple Presentations, Including New Late-Breaking Data for its mutCALR-Directed Monoclonal Antibody (INCA033989), Accepted for Presentation at EHA 2025

Business Wire logo

European Commission Approves ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Newly Diagnosed Stage IIb/III/IV Hodgkin Lymphoma in Combination with ECADD

Business Wire logo

TRI Launches Major Overhaul of OPRA-CM to Unlock the Full Potential of Centralized Monitoring in Clinical Trials

Louis Denis, MD, Chief Medical Officer, Byondis

Byondis Announces First Patient Dosed in Phase 1 Clinical Trial of Novel SIRPα-Directed Monoclonal Antibody BYON4228 in Patients With Advanced or Metastatic Solid Tumors

PR Newswire associated0

Sixth Global Pharma Company Selects LifeSphere NavaX for GenAI-Driven Case Processing

PR Newswire associated0

PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-line maintenance therapy for extensive-stage small cell lung cancer

PR Newswire associated0

Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)

Business Wire logo

Calm Health Expands Globally, Starting with UK and Canada

Minerva Biotechnologies - Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells

NuCana Reports First Quarter 2025 Financial Results and Provides Business Update

PR Newswire associated0

Alkermes to Participate in the 46th Annual Goldman Sachs Global Healthcare Conference